These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9280618)

  • 21. Two cases of non-alcoholic steatohepatitis with development of hepatocellular carcinoma without cirrhosis.
    Ichikawa T; Yanagi K; Motoyoshi Y; Hamasaki K; Nakao K; Toriyama K; Eguchi K
    J Gastroenterol Hepatol; 2006 Dec; 21(12):1865-6. PubMed ID: 17074033
    [No Abstract]   [Full Text] [Related]  

  • 22. [NASH -- nonalcoholic steatohepatitis].
    Blechacz B; Stremmel W
    Z Gastroenterol; 2003 Jan; 41(1):77-90. PubMed ID: 12541180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatty liver.
    Thaler H
    Tokai J Exp Clin Med; 1980 Apr; 5(2):233-42. PubMed ID: 7414634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease.
    Charlton M; Kasparova P; Weston S; Lindor K; Maor-Kendler Y; Wiesner RH; Rosen CB; Batts KP
    Liver Transpl; 2001 Jul; 7(7):608-14. PubMed ID: 11460228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of rosiglitazone in non-alcoholic steatohepatitis associated liver fibrosis].
    Nan YM; Fu N; Yu J
    Zhonghua Gan Zang Bing Za Zhi; 2008 Aug; 16(8):624-5. PubMed ID: 18752754
    [No Abstract]   [Full Text] [Related]  

  • 26. Recurrent non-alcoholic steatohepatitis in a living related liver transplant recipient.
    Saab S; Cho D; Lassman RC; Gajjar NA; Ghobrial M; Busuttil RW
    J Hepatol; 2005 Jan; 42(1):148-9. PubMed ID: 15629523
    [No Abstract]   [Full Text] [Related]  

  • 27. Silent non-alcoholic fatty liver disease-a clinical-histological study.
    Sorrentino P; Tarantino G; Conca P; Perrella A; Terracciano ML; Vecchione R; Gargiulo G; Gennarelli N; Lobello R
    J Hepatol; 2004 Nov; 41(5):751-7. PubMed ID: 15519647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Non-alcoholic steatohepatitis].
    Vecchione R; Giannatiempo R; Fiorentino F; Terracciano L
    Pathologica; 2003 Oct; 95(5):252. PubMed ID: 14989001
    [No Abstract]   [Full Text] [Related]  

  • 29. Non-alcoholic steatohepatitis and metabolic syndrome.
    Machado M; Cortez-Pinto H
    Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):637-42. PubMed ID: 16912563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis.
    Satapathy SK; Sakhuja P; Malhotra V; Sharma BC; Sarin SK
    J Gastroenterol Hepatol; 2007 May; 22(5):634-8. PubMed ID: 17444848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C.
    Sanyal AJ; Banas C; Sargeant C; Luketic VA; Sterling RK; Stravitz RT; Shiffman ML; Heuman D; Coterrell A; Fisher RA; Contos MJ; Mills AS
    Hepatology; 2006 Apr; 43(4):682-9. PubMed ID: 16502396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease.
    Haukeland JW; Konopski Z; Linnestad P; Azimy S; Marit Løberg E; Haaland T; Birkeland K; Bjøro K
    Scand J Gastroenterol; 2005 Dec; 40(12):1469-77. PubMed ID: 16293559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exchange transfusions for intractable hepatic coma. Successful treatment of a patient with alcoholic hepatitis.
    Szwed JJ; Grisell TW; Mendenhall CL
    Arch Intern Med; 1969 Apr; 123(4):441-4. PubMed ID: 5778124
    [No Abstract]   [Full Text] [Related]  

  • 34. [Non-alcoholic steatohepatitis: therapeutic management].
    Cadranel JF
    Gastroenterol Clin Biol; 2003; 27(8-9):799-805. PubMed ID: 14586251
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatocellular carcinoma with silent and cirrhotic non-alcoholic steatohepatitis, accompanying ectopic liver tissue attached to gallbladder.
    Ikeda H; Suzuki M; Takahashi H; Kobayashi M; Okuse N; Moriya H; Koike J; Maeyama S; Yotsuyanagi H; Itoh F
    Pathol Int; 2006 Jan; 56(1):40-5. PubMed ID: 16398679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology and natural history of NAFLD and NASH.
    Ong JP; Younossi ZM
    Clin Liver Dis; 2007 Feb; 11(1):1-16, vii. PubMed ID: 17544968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation.
    Ayata G; Gordon FD; Lewis WD; Pomfret E; Pomposelli JJ; Jenkins RL; Khettry U
    Hum Pathol; 2002 Nov; 33(11):1098-104. PubMed ID: 12454814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient with hepatitis B and alcoholic liver disease before and after liver transplantation.
    Ward SC; Chang CY; Peng L; Liu LU
    Semin Liver Dis; 2009 May; 29(2):233-7. PubMed ID: 19387922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease.
    Gulsen M; Yesilova Z; Bagci S; Uygun A; Ozcan A; Ercin CN; Erdil A; Sanisoglu SY; Cakir E; Ates Y; Erbil MK; Karaeren N; Dagalp K
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1448-55. PubMed ID: 16105135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review article: the metabolic syndrome and non-alcoholic fatty liver disease.
    Loria P; Lonardo A; Carulli L; Verrone AM; Ricchi M; Lombardini S; Rudilosso A; Ballestri S; Carulli N
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():31-6. PubMed ID: 16225469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.